With the adoption of Disposable and Single-use manufacturing equipment on the rise, it is logical there is an industry push to develop a standardised set of testing requirements to thoroughly evaluate the impact of extractable and leachable (E&L) contaminants on patient safety. The main objectives of this work are to critically evaluate the preliminary research previously undertaken on the subject area of Single-Use Systems (SUS) with emphasis on the data currently generated from vendors of single-use systems, the need for harmonised supplier data, current methodologies and best practices employed for E&L testing, and also identification of key areas that warrant further study.
This will be accomplished using both quantitative and qualitative research methods where primary data is sourced directly from interviews with experienced professionals in the field. The secondary information is obtained from the critical analysis of scientific publications, scholarly articles, databases, and use of statistical data generated from recent surveys on the challenges E&L present and how industry have addressed this matter thus far.
From an extractables and leachables viewpoint the regulatory outlook is still quite uncertain. Some SUS suppliers deliver a very strong data package which satisfies the needs of the drug product manufacturer while others fail in this regard. So, in that sense the evaluation of extractables and leachables remains a grey area at present. The challenge for the industry now is to achieve uniformity of data across multiple single-use vendors to facilitate end user risk assessment and compliance for future regulatory submissions and better patient care.
Table of Contents
1. Introduction
2. Literature Review
2.1 Overview
2.1.1 History
2.2 Single-Use Technology (SUT)
2.2.1 Advantages of SUT
2.2.2 Concerns with SUT
2.3 Regulatory Outlook
2.4 Primary Data
3. Current Methodologies for E&L testing
3.1 Extractable and Leachable studies
3.1.1 Solvent selection
3.1.2 Worst-case conditions
3.2 Extraction Techniques
3.3 Analytical techniques
3.4 Evaluation of Data
3.5 Leachables Studies
3.5.1 Application-specific evaluation
4. Regulatory Perspective
4.1 Official guidance documents
4.2 Industry groups contributions
4.3 Current Regulatory Outlook
5. Risk Assessment & Current Best Practice
5.1 Risk Identification
5.2 Risk Analysis
5.2.1 Quality by Design
5.3 Risk Control
5.4 Risk reduction
6. Conclusion
6.1 Discussion
6.2 Future trends and improvements
7. Bibliography
8. Appendices
8.1 Appendix – A
8.2 Appendix – B
8.3 Appendix – C
8.4 Appendix – D
8.5 Appendix – E
Research Objectives and Core Themes
The primary research objective of this work is to critically evaluate current practices regarding Extractable and Leachable (E&L) assessments within Single-Use Systems (SUS), aiming to identify industry-wide challenges and propose paths toward standardization and improved patient safety.
- The evaluation of E&L contaminants as a critical risk factor for drug product safety.
- The necessity for harmonized vendor-supplied data and standardized testing protocols.
- Application of Quality by Design (QbD) and robust risk management strategies.
- Examination of current methodologies, extraction techniques, and analytical tools for leachables.
- The regulatory landscape and the challenges arising from the absence of unified industry standards.
Excerpt from the Dissertation
3.1.1 Solvent selection
In terms of mimicking or modelling solutions for an extractables study, the principle of “like dissolves like” should be applied. This means that the likely leachable compounds that may be present in the single-use component would have a certain affinity for the chosen solvent. This may be due to similar functionality, polarity, or solubility for instance. The chosen solvent should be capable of interacting with the pharmaceutical matrix causing the migration of extractables from the interior towards the surface of the material. The use of organic solvents is known to produce a swelling effect which causes the pore size of the matrix to enlarge and thus, facilitate the migration of these compounds.
In order to select a relevant model solution, the constituents of the process fluid and its overall characteristics must first be examined. The Product Quality Research Institute (PQRI) recommends that solvent selection should begin with knowledge of the test article function, its constituents, and drug product formulation. In relation to the characteristics of the process fluid, the following would be important questions, is the process fluid highly aqueous, organic, oily, or does it possess an extreme pH. The answers to these questions would narrow the choice of potential solvents to one that possesses similar properties. It is proposed that any non-volatile constituents in the process fluid which is greater than 10% should be modelled with a volatile equivalent. In this way, a model is achieved that has equal or greater extracting strength and the same selectivity for leachables as the original process fluid.
Although water is one of the main constituents of many drug product formulations, it is a poor extraction solvent by itself for monomers, oligomers, and polymer additives. A combination of water with an organic solvent is suggested to achieve a more powerful extraction potential. In the same way, organic solvents are chosen with a wide range of polarities and boiling points, it is equally important that water of varying pH is used also. Similarly, water of different acidity or basicity can be viewed as different organic solvents with different solvating power which is required to evaluate a full suite of potential extractable compounds (Feinberg et al., 2012).
Summary of Chapters
1. Introduction: Presents the growth of Single-Use Systems in biomanufacturing and introduces the central research problem regarding E&L contaminants.
2. Literature Review: Details the history, advantages, and concerns associated with SUT, while examining the regulatory uncertainty and the current state of industry data.
3. Current Methodologies for E&L testing: Evaluates scientific approaches to extraction, solvent selection, and analytical characterization of components.
4. Regulatory Perspective: Discusses the legislative basis for E&L testing and the role of various industry groups in driving standardization.
5. Risk Assessment & Current Best Practice: Focuses on the implementation of risk management, Quality by Design (QbD), and supply chain control to minimize safety risks.
6. Conclusion: Summarizes the study's findings and outlines future trends, emphasizing the need for standardized protocols to ensure patient safety.
Keywords
Single-Use Systems, Extractables, Leachables, Biopharmaceutical Manufacturing, Risk Assessment, Quality by Design, Regulatory Standards, Solvent Selection, Patient Safety, Supply Chain, Analytical Techniques, Polymer Compatibility.
Frequently Asked Questions
What is the core focus of this research?
This research provides a comprehensive account of the challenges associated with the assessment of Extractable and Leachable (E&L) compounds in the biopharmaceutical industry, particularly concerning the adoption of Single-Use Systems.
What are the central themes discussed in the work?
The work covers the transition from stainless steel to single-use technology, the specific risks of chemical migration, the impact on drug quality, and the urgent industry need for standardized testing and risk management.
What is the primary goal of the dissertation?
The goal is to critically evaluate existing research on SUT, highlight concerns regarding vendor-supplied data, and examine current best practices for ensuring patient safety and regulatory compliance.
Which scientific methods are analyzed for E&L evaluation?
The study examines controlled extraction studies (CES), the application of "like dissolves like" for solvent selection, extraction techniques such as maceration and reflux, and various hyphenated analytical methods like GC-MS and LC-MS.
What topics are covered in the main body chapters?
The main body focuses on existing industry literature, methodologies for characterizing extractables, current regulatory guidance, risk assessment models, and strategies for risk control within the supply chain.
Which keywords best characterize this work?
Key terms include Single-Use Systems, Extractables, Leachables, Biomanufacturing, Quality by Design, Risk Assessment, and Regulatory Compliance.
How does the author propose to improve data consistency among vendors?
The author argues for the adoption of standardized protocols for extractables testing and enhanced communication between vendors and end-users regarding polymer composition and change control.
What role does Quality by Design (QbD) play in the research?
QbD is presented as a vital strategy for integrating quality into the manufacturing process from the start, rather than relying on final-product testing to identify potential leachable issues.
- Quote paper
- Suzanne Culleton (Author), 2015, Disposable Technology and Single-Use Systems. Regulatory Perspective, Best Practices and Future Trends of Extractables and Leachables, Munich, GRIN Verlag, https://www.grin.com/document/507038
